Exact Mass: 402.25184440000004
Exact Mass Matches: 402.25184440000004
Found 500 metabolites which its exact mass value is equals to given mass value 402.25184440000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Gamabufogenin
Gamabufogenin is a steroid lactone. It is functionally related to a bufanolide. Gamabufotalin is a natural product found in Bufotes viridis, Bufo, and other organisms with data available. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Gamabufotalin (Gamabufagin), a main active compound isolated from Chinese medicine Chansu, has been shown to strongly inhibit cancer cell growth and inflammatory response. Gamabufotalin could inhibite angiogenesis by inhibiting the activation of VEGFR-2 signaling pathways. Gamabufotalin (Gamabufagin), a main active compound isolated from Chinese medicine Chansu, has been shown to strongly inhibit cancer cell growth and inflammatory response. Gamabufotalin could inhibite angiogenesis by inhibiting the activation of VEGFR-2 signaling pathways.
Telobufotoxin
Telocinobufagin is a steroid lactone. It is functionally related to a bufanolide. Telocinobufagin is a natural product found in Bufo gargarizans, Bufo bufo, and other organisms with data available. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Telocinobufagin is one of anti-hepatoma constituent in Venenum Bufonis. Telocinobufagin is one of anti-hepatoma constituent in Venenum Bufonis.
ST 24:4;O5
C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Same as: D01693
Merodesmosine
Aminoacid from reduced elastin. Merodesmosine is found in animal foods. Merodesmosine is found in animal foods. Aminoacid from reduced elasti
Lucidone A
Lucidone A is found in mushrooms. Lucidone A is a constituent of Ganoderma lucidum (reishi)
Gamabufotalin
Telocinobufagin
3-dehydrocholate
3-dehydrocholate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3-dehydrocholate can be found in a number of food items such as kale, cucurbita (gourd), atlantic herring, and spearmint, which makes 3-dehydrocholate a potential biomarker for the consumption of these food products. Dehydrocholic acid is a synthetic bile acid, manufactured by the oxidation of cholic acid. It acts as a hydrocholeretic, increasing bile output to clear increased bile acid load .
Clascoterone
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
17-Succinoyloxy-ent-cleroda-3,13(16),14-trien-15,16-oxide
3alpha,14alpha-Diacetoxy-2beta-hydroxy-1(15),8(19),9-trinervitatriene
3alpha,9,14-Trihydroxy-5beta,14beta-bufa-20,22-dienolid|3alpha,9,14-trihydroxy-5beta,14beta-bufa-20,22-dienolide
1beta,11alpha-Diacetoxy-7-oxosandaracopimar-8(14),15-dien
7beta-angeloyloxy-8alpha-isobutyryloxylongipin-2-en-1-one
2-oxo-18,19-diacetoxy-10alpha,17alpha,19alpha,20beta-(-)-cleroda-3,13(16),14-triene
(-)-(5E,12E,2S,3S,4S,9S,11S,15R)-3,15-diacetoxylathyra-5,12-dien-14-one|3beta,15beta-diacetoxylathyra-5E,12E-dien-14-one|jolkinoate A
(2E,4E,6E)-6-(1-carboxyocta-2,4,6-triene)-11,12-epoxy-9-hydroxy-11-methoxy-drim-7-ene
6-O-alpha-E-p-coumaroyl-1beta,4alpha-dihydroxyeudesmane
2alpha-isobutyryloxy-15,16-epoxylabda-7,13(16),14-trien-18-oic acid
2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl)butyryl-benzene
hexanocucurbitacin D|Hexanor-cucurbitacin D|Hexanorcucurbitacin D
(3beta,4beta,5beta,14beta)-3,4,14-Trihydroxybufa-20,22-dienolide
Di-Ac-7, 8-Epoxy-3, 12(18), 13-dolabellatriene-19, 20-diol
(1S,2R,3E,7E,11S,12R,13S)-2,13-diacetoxydolabella-3,7,18-trien-9-one
7alpha-hydroxy-8,11,13-abietatriene-18-succinic acid|abiesadine F
6alpha,12-diacetoxy-7beta-hydroxyabieta-8,11,13-triene|fortunin B
Hexanorcucurbitacin D
hexanorcucurbitacin D is a natural product found in Begonia parviflora, Cucumis melo, and other organisms with data available.
Dehydrocholic acid
Dehydrocholic acid is a synthetic bile acid, manufactured by the oxidation of cholic acid. It acts as a hydrocholeretic, increasing bile output to clear increased bile acid load. 3,7,12-trioxo-5beta-cholanic acid is an oxo-5beta-cholanic acid in which three oxo substituents are located at positions 3, 7 and 12 on the cholanic acid skeleton. It has a role as a gastrointestinal drug. It is an oxo-5beta-cholanic acid, a 7-oxo steroid, a 12-oxo steroid and a 3-oxo-5beta-steroid. It is a conjugate acid of a 3,7,12-trioxo-5beta-cholan-24-oate. Dehydrocholic acid is a synthetic bile acid that was prepared from the oxidation of cholic acid with chromic acid. It has been used for stimulation of biliary lipid secretion. The use of dehydrocholic acid in over-the-counter products has been discontinued by Health Canada.
(4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
3,7,12-Trioxo-5b-cholan-24-oic acid
BA-119-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-119-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-119-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
3,7,12-Trioxo-5a-cholan-24-oic acid
BA-128-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-128-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-128-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
Ala Gly Lys Lys
Ala Ile Ile Ser
Ala Ile Leu Ser
Ala Ile Ser Ile
Ala Ile Ser Leu
Ala Ile Thr Val
Ala Ile Val Thr
Ala Lys Gly Lys
Ala Lys Lys Gly
Ala Leu Ile Ser
Ala Leu Leu Ser
Ala Leu Ser Ile
Ala Leu Ser Leu
Ala Leu Thr Val
Ala Leu Val Thr
Pregn-4-ene-3,20-dione, 6a,17-dihydroxy-6-methyl-, 17-acetate
Pregn-4-ene-3,20-dione, 6b,17-dihydroxy-6-methyl-, 17-acetate
7,21-Dihydroxy-6a-methylpregn-4-ene-3,20-dione 17-acetate
Ala Ser Ile Ile
Ala Ser Ile Leu
Ala Ser Leu Ile
Ala Ser Leu Leu
Ala Thr Ile Val
Ala Thr Leu Val
Ala Thr Val Ile
Ala Thr Val Leu
Ala Val Ile Thr
Ala Val Leu Thr
Ala Val Thr Ile
Ala Val Thr Leu
Gly Ala Lys Lys
Gly Ile Ile Thr
Gly Ile Leu Thr
Gly Ile Thr Ile
Gly Ile Thr Leu
Gly Lys Ala Lys
Gly Lys Lys Ala
Gly Leu Ile Thr
Gly Leu Leu Thr
Gly Leu Thr Ile
Gly Leu Thr Leu
Gly Thr Ile Ile
Gly Thr Ile Leu
Gly Thr Leu Ile
Gly Thr Leu Leu
Ile Ala Ile Ser
Ile Ala Leu Ser
Ile Ala Ser Ile
Ile Ala Ser Leu
Ile Ala Thr Val
Ile Ala Val Thr
Ile Gly Ile Thr
Ile Gly Leu Thr
Ile Gly Thr Ile
Ile Gly Thr Leu
Ile Ile Ala Ser
Ile Ile Gly Thr
Ile Ile Ser Ala
Ile Ile Thr Gly
Ile Leu Ala Ser
Ile Leu Gly Thr
Ile Leu Ser Ala
Ile Leu Thr Gly
Ile Ser Ala Ile
Ile Ser Ala Leu
Ile Ser Ile Ala
Ile Ser Leu Ala
Ile Thr Ala Val
Ile Thr Gly Ile
Ile Thr Gly Leu
Ile Thr Ile Gly
Ile Thr Leu Gly
Ile Thr Val Ala
Ile Val Ala Thr
Ile Val Thr Ala
Lys Ala Gly Lys
Lys Ala Lys Gly
Lys Gly Ala Lys
Lys Gly Lys Ala
Lys Lys Ala Gly
Lys Lys Gly Ala
Leu Ala Ile Ser
Leu Ala Leu Ser
Leu Ala Ser Ile
Leu Ala Ser Leu
Leu Ala Thr Val
Leu Ala Val Thr
Leu Gly Ile Thr
Leu Gly Leu Thr
Leu Gly Thr Ile
Leu Gly Thr Leu
Leu Ile Ala Ser
Leu Ile Gly Thr
Leu Ile Ser Ala
Leu Ile Thr Gly
Leu Leu Ala Ser
Leu Leu Gly Thr
Leu Leu Ser Ala
Leu Leu Thr Gly
Leu Ser Ala Ile
Leu Ser Ala Leu
Leu Ser Ile Ala
Leu Ser Leu Ala
Leu Thr Ala Val
Leu Thr Gly Ile
Leu Thr Gly Leu
Leu Thr Ile Gly
Leu Thr Leu Gly
Leu Thr Val Ala
Leu Val Ala Thr
Leu Val Thr Ala
Ser Ala Ile Ile
Ser Ala Ile Leu
Ser Ala Leu Ile
Ser Ala Leu Leu
Ser Ile Ala Ile
Ser Ile Ala Leu
Ser Ile Ile Ala
Ser Ile Leu Ala
Ser Leu Ala Ile
Ser Leu Ala Leu
Ser Leu Ile Ala
Ser Leu Leu Ala
Ser Val Val Val
Thr Ala Ile Val
Thr Ala Leu Val
Thr Ala Val Ile
Thr Ala Val Leu
Thr Gly Ile Ile
Thr Gly Ile Leu
Thr Gly Leu Ile
Thr Gly Leu Leu
Thr Ile Ala Val
Thr Ile Gly Ile
Thr Ile Gly Leu
Thr Ile Ile Gly
Thr Ile Leu Gly
Thr Ile Val Ala
Thr Leu Ala Val
Thr Leu Gly Ile
Thr Leu Gly Leu
Thr Leu Ile Gly
Thr Leu Leu Gly
Thr Leu Val Ala
Thr Val Ala Ile
Thr Val Ala Leu
Thr Val Ile Ala
Thr Val Leu Ala
Val Ala Ile Thr
Val Ala Leu Thr
Val Ala Thr Ile
Val Ala Thr Leu
Val Ile Ala Thr
Val Ile Thr Ala
Val Leu Ala Thr
Val Leu Thr Ala
Val Ser Val Val
Val Thr Ala Ile
Val Thr Ala Leu
Val Thr Ile Ala
Val Thr Leu Ala
Val Val Ser Val
Val Val Val Ser
methyl ester
lucidone A
(2E,5E)-2,5-BIS[(4-(DIETHYLAMINO)PHENYL)METHYLENE]CYCLOPENTANONE
4,4-di(2-ethylhexyl)-4H-cyclopenta[2,1-b:3,4-b]dithiophene
Bepridil hydrochloride
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
ALPHA,ALPHA-BIS(4-HYDROXY-3,5-DIMETHYLPHENYL)-1,4-DIISOPROPYLBENZENE
17α-hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione 3,20-bis(ethylene acetal)
1,1-[Methylenebis(4,1-phenyleneoxy)]bis[3-(ethylamino)-2-propanol]
C23H34N2O4 (402.25184440000004)
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid
Acacia senegal, ext.
Clascoterone
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
4-(cyclopropylmethyl)-1-(1H-pyrrolo[2,3-c]pyridin-3-ylmethyl)spiro[3,5-dihydro-1,4-benzoxazepine-2,4-piperidine]
(3E,5E,7E,10R,12Z,14E,17R,18S,22S)-22-ethyl-10,18-dihydroxy-17-methyl-1-oxacyclodocosa-3,5,7,12,14-pentaene-2,16-dione
(3E,5E,9E,11Z,17E,19E)-8,14,16-trihydroxy-24-methyl-1-oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one
(-)-(5E,12E,2S,3S,4S,9S,11S,15R)-3,15-diacetoxylathyra-5,12-dien-14-one
A lathyrane diterpenoid isolated from the roots of Euphorbia micractina.
(2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid
(4R)-4-[(10S,13R,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
Ala-Leu-Leu-Ser
A tetrapeptide composed of L-alanine, two L-leucine units, and L-serine joined in sequence by peptide linkages.
1-[4-(2,3-Dimethylphenyl)piperazin-1-yl]-3-(4,4,6-trimethyl-2-sulfanylidene-1,3-diazinan-1-yl)propan-1-one
(1R,2R,6R)-6-[(2E,6E,10E)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-3-methyl-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
4-[(5S,10S,13R,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
(1R,2S,6R)-3-methoxy-5-oxo-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
15-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxopentadecanoic acid
(14R)-14-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxopentadecanoic acid
N-benzyl-N-[3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl]aniline hydrochloride
N-[(2R,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3R,6R)-6-[2-[4-[(dimethylamino)methyl]triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-2-pyridin-3-ylacetamide
N-[(2R,3R,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2R,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2R,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
(4R)-4-[(5S,8S,9R,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
7alpha,12alpha-Dihydroxy-3-oxochola-1,4-dien-24-oic Acid
yanuthone L
A class I yanuthone that is yanuthone K in which a hydrogen of the pro-E methyl group at the terminus of the farnesyl substituent has been replaced by a hydroxy group. Isolated from the filamentous fungus Aspergillus niger, it shows antifungal activity towards the pathogenic yeast Candida albicans (IC50 = 17.0 +-1.9 muM).
yanuthone X1
A class II yanuthone that is yanuthone X2 in which the hydroxy group at position 4 of the 5,6-epoxycyclohex-2-en-1-one core has been converted to the corresponding acetate ester. Like yanuthone X2, yanuthone X1 has been isolated from the filamentous fungus Aspergillus niger, but shows much lower antifungal activity towards the pathogenic yeast Candida albicans than yanuthone X2 (IC50 >100 muM for yanuthone X1, compared with = 51.7 +-4.7 muM for yanuthone X2).
19-Hydroxybufalin
19-Hydroxybufalin is a bufadienolide, inhibits epithelial-mesenchymal transition and attenuates the migration and invasion of PC3 cells[1].
methyl (1s,2r,5r,10r,11r,13s,14s)-14-hydroxy-2,6,6,10,13-pentamethyl-16-methylidene-7,15-dioxotetracyclo[11.2.1.0²,¹¹.0⁵,¹⁰]hexadecane-1-carboxylate
(1e,10z,12e,15z,17e)-3,20,22-trihydroxy-7-methyl-3,4,5,6,7,14,18a,19,20,21,22,22a-dodecahydro-8-benzoxacycloicosin-9-one
(4bs,8as,9r,10r)-9-(acetyloxy)-10-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl acetate
(1r,5r,7s,12s,13s,14s)-13-(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-1-yl acetate
3-{5-[(2,5-dihydroxy-3-methylphenyl)methyl]-5,6,8a-trimethyl-2-oxo-hexahydro-1h-naphthalen-1-yl}propanoic acid
[(1r,2s,5s,9s,13r)-2-(acetyloxy)-5,9-dimethyl-14-methylidene-6-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
2-(hydroxymethyl)-6-{[7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-octahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol
{5-[(acetyloxy)methyl]-1,2-dimethyl-1-(3-methylidenepent-4-en-1-yl)-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-4a-yl}methyl acetate
5,5'-bis(prop-2-en-1-yl)-2'-({1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl}oxy)-[1,1'-biphenyl]-2-ol
1-[(1s,4as,11ar)-1-(acetyloxy)-7-methyl-11-methylidene-1h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-4-methylpent-3-en-1-yl acetate
(3s)-2-[(1s,3r,4s,4as)-3-(acetyloxy)-4-methyl-7-methylidene-2,3,4,4a,5,6-hexahydro-1h-naphthalen-1-yl]-6-methyl-4-oxohept-5-en-3-yl acetate
[(3br,5as,6s,9as,9bs)-6-[(acetyloxy)methyl]-3b,6-dimethyl-4h,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-c]furan-9a-yl]methyl acetate
5-[(1r,3as,3br,5ar,7s,9ar,9bs,11ar)-3a,7-dihydroxy-9a-(hydroxymethyl)-11a-methyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]pyran-2-one
(3r,3as,5r,8ar)-3a-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3,4,5,8-hexahydroazulen-5-yl 3,4-dimethoxybenzoate
(1s,5r,6s,8r)-8-{1-[(1r,3as,8as)-4,4,8a-trimethyl-8-methylidene-hexahydro-1h-azulen-1-yl]ethenyl}-3-oxo-2,7-dioxabicyclo[3.2.1]octan-6-yl acetate
3-[(1s,6s)-6-isopropyl-3-methylcyclohex-2-en-1-yl]-3',5-bis(prop-2-en-1-yl)-[1,1'-biphenyl]-2,4'-diol
3-(hydroxymethyl)-5-oxo-6-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
3-[(1s,6s)-6-isopropyl-3-methylcyclohex-2-en-1-yl]-5,5'-bis(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol
[5-(acetyloxy)-2-(2-methyl-5-oxocyclopent-3-en-1-yl)-3-(6-methylhepta-2,5-dien-2-yl)cyclopentyl]methyl acetate
(1r,2s,3as,4r,12as)-4-(acetyloxy)-3a,6,10-trimethyl-11-oxo-1-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h,12h,12ah-cyclopenta[11]annulen-2-yl acetate
(2s,3r,4s,5s,6r)-2-{[(1s,4as,7s,8as)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(4as,5r,6s,8ar)-3,4a-dimethyl-5-[(3-methylbutanoyl)oxy]-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-6-yl (2e)-2-methylbut-2-enoate
2-hydroxy-2-(2-methoxy-2-oxoethyl)-3-tetradecylbutanedioic acid
(2r)-1-(3-acetyl-4-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,6-dihydroxy-5-methylphenyl)-2-methylbutan-1-one
(1e,3e,6e,10z)-3-[(acetyloxy)methylidene]-7-methyl-11-(4-methylpent-3-en-1-yl)-12-oxododeca-1,6,10-trien-1-yl acetate
(1r,2s,4s,5s,7r,8r)-3,3,7,9-tetramethyl-5-[(2-methylpropanoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undec-9-en-4-yl (2z)-2-methylbut-2-enoate
(1s,3s,5r,7s,10s,14r,15s,17r,18s)-15-acetyl-7,17-dihydroxy-6,6,10,14,18-pentamethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-13-one
(2r)-2-[(2s,3r,4r)-3,4-dimethyl-5-oxo-3-(6,8,10-trimethyl-9-oxododeca-1,3,5,7-tetraen-1-yl)oxolan-2-yl]propanoic acid
[(1s,2r,3r,5r)-5-(acetyloxy)-2-[(1r,2r)-2-methyl-5-oxocyclopent-3-en-1-yl]-3-[(2z)-6-methylhepta-2,5-dien-2-yl]cyclopentyl]methyl acetate
[(3br,5ar,6s,7s,9ar,9br)-7-(acetyloxy)-3b,6,9a-trimethyl-4h,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-c]furan-6-yl]methyl acetate
(3r,3as,4s,8ar)-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl 3,4-dimethoxybenzoate
methyl 4-hydroxy-3-{[1-(hydroxymethyl)-2,4a-dimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-methoxybenzoate
(1r,3e,5r,7s,10e,12s,13s,14s)-13-(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-1-yl acetate
(2s,3r,4s,5s,6r)-2-({2-[(2s,4as,8s,8as)-8-hydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
4-{[(1s,2r,4ar,8ar)-1-[2-(furan-3-yl)ethyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methoxy}-4-oxobutanoic acid
1β-hydroxybufalin
{"Ingredient_id": "HBIN002411","Ingredient_name": "1\u03b2-hydroxybufalin","Alias": "NA","Ingredient_formula": "C24H34O5","Ingredient_Smile": "CC12CCC3C(C1(CCC2C4=COC(=O)C=C4)O)CCC5C3(C(CC(C5)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9858","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl)butyryl-benzene
{"Ingredient_id": "HBIN005123","Ingredient_name": "2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl)butyryl-benzene","Alias": "AC1NSTGW; 1-[3-Acetyl-2,6-dihydroxy-5-methyl-4-[(3,7-dimethyl-2,6-octadienyl)oxy]phenyl]-2-methyl-1-butanone; 1-[3-acetyl-4-[(2E)-3,7-dimethylocta-2,6-dienoxy]-2,6-dihydroxy-5-methylphenyl]-2-methylbutan-1-one; 2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl) butyryl-benzene","Ingredient_formula": "C24H34O5","Ingredient_Smile": "CCC(C)C(=O)C1=C(C(=C(C(=C1O)C)OCC=C(C)CCC=C(C)C)C(=O)C)O","Ingredient_weight": "402.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14136;SMIT19036","TCMID_id": "26099","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5315778","DrugBank_id": "NA"}